LINKING PATIENTS TO QUALITY TESTS AT AFFORDABLE COSTS
Tuberculosis | HCV | HIV
IPAQT AT A GLANCE
IPAQT (Initiative for Promoting Affordable and Quality TB Tests) is an initiative started in 2013 to bring RNTCP or WHO-approved tuberculosis tests at affordable prices to patients in the private sector. In India more than 50% of the population still seek care for TB in the private sector. Back in 2012, TB diagnosis in the private sector was driven by excess use of unreliable serological test and high cost of WHO endorsed diagnostics tests. IPAQT brought together various private labs with the support of test manufacturers and other major stakeholders to:
Bring down the price for quality TB tests for up to 50% in the private sector
Promote the use of these tests by building awareness among health providers, laboratories and patients.
“Early and acccurate diagnosis is the first step towards correct treatment.”
WHAT WE DO?
IPAQT partner labs in India offer the below mentioned WHO approved TB tests at or below the mentioned ceiling prices.
MGIT Liquid culture (LC) is significantly faster: the average time-to-growth detection with liquid culture is 10 to 12 days, as opposed to four to six weeks with traditional solid culture. MGIT is also recommended for DST.
BacT/Alert is also an automated microbial detection system . Liquid culture systems are up to 20% more sensitive than solid culture and therefore recommended gold standard for detection of MTB.
Xpert MTB/Rif is a molecular test for detection of MTB and resistance to rifampicin (RIF) by nucleic acid amplification test (NAAT) in less than two hours. GeneXpert can be used for both pulmonary and Extra-pulmonary samples.
MTB - ₹2200
HIV Viral Load- ₹2800
HCV Viral Load- ₹2600
The Genotype MTBDRplus test is a WHO-endorsed line-probe assay (LPA) for the rapid m tuberculosis complex (MTB) and mutations conferring resistance to rifampin (RIF) and isoniazid (INH) in AFB smear-positive sputum specimens.
HAIN LPA -₹1800